The lancet oncology
-
The lancet oncology · Jul 2022
Defining availability of 100 essential diagnostic items for children with cancer and gaps in implementing WHO recommendations: Global CEDx Working Group survey.
WHO has established recommendations to guide governments' prioritisation of essential diagnostic tests, technologies, and priority medical devices for patients with cancer. Despite many countries committing to expanding resources for children with cancer since the WHO Global Initiative for Childhood Cancer was launched in 2018, data on the availability of essential diagnostics and on local awareness and adoption of WHO recommendations in low-income and middle-income countries are scarce. ⋯ American Lebanese Syrian Associated Charities and St Jude Children's Research Hospital.
-
The lancet oncology · Jul 2022
Screening and eradication of Helicobacter pylori to prevent gastric cancer in indigenous Taiwanese communities: a population-based study and development of an index-case method.
Gastric cancer is one of the leading causes of cancer death, particularly in Asia and South America. Screening and eradication of Helicobacter pylori is recognised as an advantageous solution to reduce the disparities in the incidence of this cancer. However, the deployment of such policies is not yet sufficiently advanced in high-incidence areas. Our study aimed to show the acceptability and feasibility of an index-case method to implement a screening and eradication policy in high-risk populations living in Taiwanese indigenous communities. ⋯ Health Promotion Administration, Ministry of Health and Welfare, Taiwan (grant number A1101008).
-
The lancet oncology · Jul 2022
Multimorbidity among patients with digestive cancers patients in Chile: a nationwide database study.
Multimorbidity, the presence of two or more chronic diseases in one individual, affects an increasing number of patients worldwide, creating one of the main challenges in global public health. Multimorbidity results in higher mortality, lower quality of life, and individual risks, such as polypharmacy and exposure to complex therapeutic regimens. In Chile, five of the top ten cancers with the highest mortality rates affect the digestive system. To our knowledge, this is the first study based on a national-wide database focused on multimorbidity in patients with cancer in Chile. Our objective was to characterise multimorbidity and establish the chronic diseases and combinations thereof that most contribute to multimorbidity in patients with digestive cancers in Chile. ⋯ National Agency for Research and Development (reference 21210439).